Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer Ingelheim

Showing 15 posts of 111 posts found.

lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015
Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …

News
BI building

Boehringer Ingelheim launches Spiolto for COPD

July 2, 2015
Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi

Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …

News

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015
Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …

News
Boehringer image

Boehringer Ingelheim and Bayer ‘taking the lead’ in social media

April 22, 2015
Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld

Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …

News
Boehringer image

Boehringer chases approval for anti-Pradaxa drug

March 3, 2015
Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa, bleeding, dabigatran etexilate, idarucizumab

Boehringer Ingelheim is launching new drug applications for its investigational treatment to reverse the effects of its blood-thinning drug Pradaxa. …

News
Perrigo image

Perrigo acquires Omega for $4.5 billion

November 7, 2014
Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega

In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …

News
boehringer_angle_22

Boehringer pays $600m for cancer vaccine deal

September 19, 2014
Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1

Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …

News

Boehringer and InterMune data on IPF drugs impress

May 19, 2014
Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis

Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …

News

New managing director for Boehringer Ingelheim UK

January 13, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins

Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …

Appointment

BI leukaemia drug gains FDA breakthrough status

September 18, 2013
Research and Development, Sales and Marketing Boehringer Ingelheim, FDA, acute myeloid leukaemia, breakthrough status

News

Boehringer celebrates 50,000 Facebook ‘likes’

August 22, 2013
Medical Communications, Sales and Marketing Boehringer Ingelheim, Facebook, Janssen, Psoriasis 360, likes

News

High cure rate for Boehringer HCV drug

June 11, 2013
Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …

News

Boehringer unveils biopharma plant plan for China

June 6, 2013
Manufacturing and Production Boehringer Ingelheim, China

Boehringer Ingelheim has said it intends to construct a cell-culture biopharmaceutical production facility in China offering contract R&D and manufacturing …

News
Complications combat image

Boehringer and Lilly launch diabetes game

June 4, 2013
Medical Communications Boehringer Ingelheim, combat, lilly

Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …

News
Boehringer image

Boehringer calls for ‘game changing’ ideas in health

January 29, 2013
Medical Communications, Research and Development, Sales and Marketing Ashoka Changemakers, Boehringer Ingelheim

Boehringer Ingelheim has teamed up with a social entrepreneur network to promote health projects in developing countries. This is the …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024